Table 1.
Demographics, Medical History, and Home Medications Stratified by BMI Category
| Variable | BMI Category (kg/m2)
|
||||
|---|---|---|---|---|---|
| Normal Weight (18.5 to <25)
|
Overweight (25 to <30)
|
Class I Obese (30 to <35)
|
Class II Obese (35 to <40)
|
Class III Obese (≥40)
|
|
| (n = 11,780) | (n = 19,391) | (n = 11,234) | (n = 4,376) | (n = 2,548) | |
| Demographics | |||||
| BMI (kg/m2) | 23.1 (21.7–24.1) | 27.4 (26.3–28.7) | 32.0 (30.9–33.3) | 36.9 (35.9–38.1) | 43.4 (41.4–47.2) |
| Age (yrs) | 66 (55–78) | 60 (52–71) | 58 (50–67) | 56 (49–65) | 55 (48–64) |
| Female | 4,446 (37.7%) | 4,671 (24.1%) | 2,962 (26.4%) | 1,371 (31.3%) | 1,094 (42.9%) |
| Race/ethnicity | |||||
| Women (n = 14,544) | |||||
| Caucasian | 3,878 (87.7%) | 3,962 (85.4%) | 2,453 (83.7%) | 1,123 (82.4%) | 876 (80.7%) |
| Black | 273 (6.2%) | 423 (9.1%) | 327 (11.2%) | 173 (12.7%) | 166 (15.3%) |
| Asian | 92 (2.1%) | 46 (1.0%) | 26 (0.9%) | 5 (0.4%) | 1 (0.1%) |
| Hispanic | 104 (2.4%) | 142 (3.1%) | 69 (2.4%) | 39 (2.9%) | 26 (2.4%) |
| Other | 73 (1.7%) | 68 (1.5%) | 56 (1.9%) | 23 (1.7%) | 17 (1.6%) |
| Men (n = 34,785) | |||||
| Caucasian | 6,034 (82.8%) | 12,584 (86.1%) | 7,163 (87.2%) | 2,607 (87.3%) | 1,256 (86.8%) |
| Black | 604 (8.3%) | 877 (6%) | 508 (6.2%) | 195 (6.5%) | 125 (8.6%) |
| Asian | 221 (3.0%) | 215 (1.5%) | 53 (0.6%) | 17 (0.6%) | 5 (0.3%) |
| Hispanic | 270 (3.7%) | 618 (4.2%) | 347 (4.2%) | 115 (3.9%) | 46 (3.2%) |
| Other | 162 (2.2%) | 317 (2.2%) | 143 (1.7%) | 51 (1.7%) | 15 (1.0%) |
|
| |||||
| Medical history | |||||
| Current/recent smoker | 5,299 (45.0%) | 8,355 (43.1%) | 4,764 (42.4%) | 1,872 (42.8%) | 1,051 (41.2%) |
| Hypertension | 6,698 (56.9%) | 11,343 (58.5%) | 7,282 (64.8%) | 3,032 (69.3%) | 1,881 (73.8%) |
| Dyslipidemia | 5,109 (43.4%) | 9,647 (49.7%) | 6,063 (54.0%) | 2,457 (56.1%) | 1,427 (56.0%) |
| Diabetes mellitus | 1,749 (14.8%) | 3,788 (19.5%) | 3,049 (27.1%) | 1,538 (35.1%) | 1,110 (43.6%) |
| Prior MI | 2,265 (19.2%) | 3,602 (18.6%) | 2,203 (19.6%) | 915 (20.9%) | 530 (20.8%) |
| Prior PCI | 2,140 (18.2%) | 3,638 (18.8%) | 2,289 (20.4%) | 972 (22.2%) | 545 (21.4%) |
| Prior CABG | 824 (7.0%) | 1,373 (7.1%) | 800 (7.1%) | 309 (7.1%) | 141 (5.5%) |
| Atrial fibrillation or flutter | 254 (5.1%) | 287 (3.5%) | 166 (3.4%) | 78 (4.2%) | 38 (3.2%) |
| Prior stroke | 781 (6.6%) | 879 (4.5%) | 473 (4.2%) | 176 (4.0%) | 107 (4.2%) |
| Peripheral artery disease | 908 (7.7%) | 1,007 (5.2%) | 507 (4.5%) | 174 (4.0%) | 141 (5.5%) |
| Prior CHF | 726 (6.2%) | 780 (4.0%) | 506 (4.5%) | 230 (5.3%) | 192 (7.5%) |
|
| |||||
| Home medications | |||||
| Aspirin | 3,877 (32.9%) | 6,542 (33.7%) | 3,882 (34.6%) | 1,555 (35.5%) | 876 (34.4%) |
| Clopidogrel | 1,122 (9.5%) | 1,643 (8.5%) | 1,025 (9.1%) | 444 (10.1%) | 288 (11.3%) |
| Beta-blockers | 3,178 (27.0%) | 5,031 (25.9%) | 3,151 (28.0%) | 1,366 (31.2%) | 841 (33.0%) |
| ACE inhibitors | 2,261 (19.2%) | 3,950 (20.4%) | 2,577 (22.9%) | 1,140 (26.1%) | 706 (27.7%) |
| Angiotensin receptor blockers | 798 (6.8%) | 1,430 (7.4%) | 1,050 (9.3%) | 470 (10.7%) | 305 (12.0%) |
| Aldosterone-blocking agents | 126 (1.1%) | 158 (0.8%) | 125 (1.1%) | 59 (1.3%) | 48 (1.9%) |
| Statins | 3,091 (26.2%) | 5,658 (29.2%) | 3,511 (31.3%) | 1,466 (33.5%) | 879 (34.5%) |
Values are median (interquartile range) or n (%).
ACE = angiotensin-converting enzyme; BMI = body mass index; CABG = coronary artery bypass graft surgery; CHF = congestive heart failure; MI = myocardial infarction; PCI = percutaneous coronary intervention.